Amphia Premature Infant Pain Study
APIP
1 other identifier
interventional
75
1 country
1
Brief Summary
Last thirty years, many research was performed concerning pain in the newborn. These investigations showed us the negative effects of pain in the neonatal period. Our research concerns the choice of analgesics for the premature newborn during a heel lance. Newborns with a gestational age of 32-37 weeks are randomly assigned over three groups. They can receive breastfeeding, during the heel lance, a bottle with supplemental breast milk or sucrose. The primary objective of the Amphia Premature Infant Pain study, is to investigate whether there is a difference in PIPP-scores in premature newborns who undergo a heel lance, receiving breast milk or sucrose. Our hypothesis is that the PIPP-score will be lower in newborns receiving breast milk compared to sucrose. And the investigators presume that breast feeding has the same analgesic effect as giving supplemental breast milk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 23, 2010
CompletedFirst Posted
Study publicly available on registry
January 13, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedJanuary 17, 2019
January 1, 2019
1.6 years
April 23, 2010
January 16, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain scores assessed by the PIPP score
The primary outcome in this trial is the PIPP-score.The PIPP-score is a multidimensional pain assessment measure developed in 1995 . The PIPP-score is validated for procedural and post-operative pain in premature and term newborns.
The PIPP score will be assessed during a heellance. This heellance will be performed after one day of life and before two months.
Secondary Outcomes (3)
Pain score assessed by the COMFORTneo score
The COMFORTneo score will be assessed during a heellance. This heellance will be performed after one day of life and before two months.
partial correlation between the two pain assessment tools.
up to 2 years
intra-class correlation coefficient
up to 2 years
Study Arms (3)
sucrose
ACTIVE COMPARATORIn the third group, newborns receive sucrose 1ml 24% two minutes before procedure, followed by non-nutritive sucking. During the procedure the newborn lies in his cot.
supplemental breast milk
ACTIVE COMPARATORIn group two, the newborns receive supplemental breast milk, lying in the arms of a nurse during the heel lance.
Breast feeding
ACTIVE COMPARATORNewborns who are assigned to group one, receive breastfeeding during the blood sample and thereby have skin-skin contact between mother and child.
Interventions
Newborns who are assigned to group one, receive breastfeeding during the blood sample and thereby have skin-skin contact between mother and child.
In group two, the newborns receive supplemental breast milk, lying in the arms of a nurse during the heel lance.
In the third group, newborns receive sucrose 1ml 24% two minutes before procedure, followed by non-nutritive sucking. During the procedure the newborn lies in his cot.
Eligibility Criteria
You may qualify if:
- born at a gestational age between 32+0 and 36+6 weeks,
- being nourished with breast milk
- the necessity for a clinical blood sample.
You may not qualify if:
- perinatal asphyxia,
- birth trauma,
- condition of cardio-respiratory instability,
- condition of serious nutritional problems with clinical evidence of gastro oesophageal reflux disease,
- drug abuse of the mother
- and application of sedative medication to mother or child.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Amphia Hospitallead
Study Sites (1)
Amphia Hospital
Breda, North Brabant, 4819 VE, Netherlands
Related Publications (1)
Simonse E, Mulder PG, van Beek RH. Analgesic effect of breast milk versus sucrose for analgesia during heel lance in late preterm infants. Pediatrics. 2012 Apr;129(4):657-63. doi: 10.1542/peds.2011-2173. Epub 2012 Mar 5.
PMID: 22392168DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
RHT v Beek, phd
Amphia Hospital Breda
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- dr. R.H.T. van Beek, Amphia Hospital, pediatric department
Study Record Dates
First Submitted
April 23, 2010
First Posted
January 13, 2011
Study Start
January 1, 2010
Primary Completion
August 1, 2011
Study Completion
April 1, 2012
Last Updated
January 17, 2019
Record last verified: 2019-01